Capitainer’s self-sampling platform allows people to collect blood samples from their fingertips, anytime and anywhere, and send the samples by regular mail to a laboratory for analysis. Our unique quantitative Dried Blood Spot (qDBS) technology combines market leading clinical accuracy with a remote self-sampling solution.
We’re excited to share that Capitainer’s state-of-the-art self-sampling technology has been featured in a comprehensive article in SelectScience. The article covers the core capabilities and unique advantages of qDBS and explores how this technology could help drive the shift to more patient centric sampling solutions in healthcare.
Conventional DBS cards have been a cornerstone of screening and diagnostics in newborns since the 1960s. However, they pose limitations when it comes to volume control, primarily due to variations in blood viscosity associated with individual hematocrit levels. This has restricted DBS cards to qualitative or semi-quantitative analyses, while most clinical tests necessitate quantitative results.
Our groundbreaking qDBS technology fundamentally addresses this problem. Built on innovative microfluidics, Capitainer’s solution ensures a fixed volume of blood is metered, overcoming the hematocrit effect and enabling the blood microsample to be used for quantitative analysis. The outcome? More accurate, reliable, and patient-friendly blood testing.
The feature emphasizes Capitainer’s ongoing commitment to making diagnostics more accessible and efficient, bringing us closer to a healthcare shift towards home- and self-sampling.
The article also covers:
- An in-depth interview with Capitainer’s CEO, Christopher Aulin, highlighting the vision and strategy driving our technology.
- Insights from leading experts Dr. Donald Chace and Dr. Timothy Garrett on the impact of qDBS in diagnostics.
- The superior performance of Capitainer’s qDBS technology in real-world population studies.
- The future applications of qDBS in diverse fields such as metabolomics and lipidomics.
Learn more about the evolution of DBS diagnostics and the exciting potential of our qDBS technology – read the full feature here.